Cefquinome sulfate lung-targeted liposome preparation and preparation method thereof

A technology of cefquinome sulfate and liposome preparation, which is applied in the field of medicine, can solve the problems of high preparation cost, damage to the injection site, and increased drug resistance of toxic and side effects, and achieve reliable curative effect and stable quality

Active Publication Date: 2015-08-12
AMICOGEN CHINA BIOPHARM CO LTD
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The cefquinome sulfate preparation currently on the market is an oil injection, which is thicker and difficult to pass through the needle. It will cause pain to the animal during injection and may cause damage to the injection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cefquinome sulfate lung-targeted liposome preparation and preparation method thereof
  • Cefquinome sulfate lung-targeted liposome preparation and preparation method thereof
  • Cefquinome sulfate lung-targeted liposome preparation and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0030] Example one:

[0031] A cefquinome sulfate lung-targeted liposome preparation is composed of the following components by weight:

[0032]

[0033] Specific steps are as follows:

[0034] (1) Precisely weigh 150g of egg yolk lecithin, 30g of cholesterol, and 0.02g of PG in 300ml of chloroform-methanol solution, and place them in a reaction vessel. The organic solvents will be removed by rotary evaporation under reduced pressure in a water bath at 35°C to form a uniform and transparent surface on the vessel wall. 的膜;

[0035] (2) Add 1g D-mannose and 20g cefquinome sulfate to 500ml water for injection, add 2mol / L sodium hydroxide solution until the drug is dissolved, add 0.2mol / L phosphate buffer to adjust the pH to 6.5, add the solution Go to the reaction vessel containing liposome film obtained in step 1), stir and emulsify and hydrate for 30 minutes at 25°C under normal pressure at a speed of 300r / min, then heat up to 30°C and stir and emulsify for 1 hour to obtain a liposome ...

Example Embodiment

[0038] Embodiment two:

[0039] A cefquinome sulfate lung-targeted liposome preparation is composed of the following components by weight:

[0040]

[0041] Specific steps are as follows:

[0042] (1) Precisely weigh 180g egg yolk lecithin, 50g cholesterol, and 0.05g BHA in 360ml chloroform-methanol solution, place them in a reaction vessel, and remove the organic solvents by rotary evaporation under reduced pressure in a water bath at 35°C, forming a uniform and transparent surface on the vessel wall 的膜;

[0043] (2) Add 2g D-mannose and 25g cefquinome sulfate to 500ml water for injection, add 2mol / L sodium hydroxide solution until the drug is dissolved, add 0.2mol / L phosphate buffer to adjust the pH to 6.5, add the solution Go to the reaction vessel containing liposome film obtained in step 1), stir and emulsify and hydrate for 30 minutes at 25°C under normal pressure at a speed of 300r / min, then heat up to 30°C and stir and emulsify for 1 hour to obtain a liposome solution. 8g of ...

Example Embodiment

[0046] Example three

[0047] A cefquinome sulfate lung-targeted liposome preparation is composed of the following components by weight:

[0048]

[0049]

[0050] Specific steps are as follows:

[0051] (1) Precisely weigh 20Kg egg yolk lecithin, 6Kg cholesterol, and 10g BHT in 40L chloroform-methanol solution, and place them in a reaction vessel. The organic solvent is removed by rotary evaporation under reduced pressure in a water bath at 35°C, forming a uniform and transparent surface on the wall of the vessel. film;

[0052] (2) Add 300g mannitol and 3Kg cefquinome sulfate to 50L water for injection, add 2mol / L sodium hydroxide solution until the drug is dissolved, add 0.2mol / L phosphate buffer to adjust the pH to 6.5, add the solution to the step 1) In the resulting reaction vessel containing the liposome film, stir emulsify and hydrate for 30 minutes at 25°C under normal pressure at a speed of 300r / min, and then heat to 30°C, stir and emulsify for 1 hour, to obtain liposome so...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention belongs to the field of medicines, relates to a new veterinary drugpreparation and particularly relates to a cefquinome sulfate lung-targeted liposome preparation and a preparation method thereof. The cefquinome sulfate lung-targeted liposome preparation is good in targeting property, is stable in quality and is high in encapsulation efficiency, is convenient to use and has an active and passive targeting function. The preparation is concentrated at the targeted organ through injection and works, thereby reducing loss of the preparation, improving curative effects and reducing toxic and side effects on other organs.

Description

technical field [0001] The invention belongs to the field of medicine, and relates to a new dosage form of veterinary medicine, in particular to a cefquinome sulfate lung-targeting liposome preparation and a preparation method thereof. Background technique [0002] Cefquinoxime is the fourth-generation cephalosporin antibiotic for animals. It is a broad-spectrum and highly effective cephalosporin antibiotic. Compared with the third-generation cephalosporin, it has a wider antibacterial spectrum and stronger bactericidal effect. Its intrinsic antibacterial activity is stronger than that of the first three generations of cephalosporins. Compared with the first three generations of cephalosporins, the fourth generation of cephalosporins requires less dosage, has a strong sensitivity to treating bacteria, has a long plasma half-life, and is toxic to the kidneys. It has a strong killing effect on Staphylococcus aureus, Streptococcus, Pseudomonas aeruginosa, Enterobacteriaceae (Es...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/127A61K31/546A61K47/26A61P11/00
Inventor 胡维智李建国杨申永王玲
Owner AMICOGEN CHINA BIOPHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products